Pharma & biotech · Technology and supplier decisions
De-risk technical and commercial decisions in quality-sensitive growth.
For industrial technology, supplier selection and value-chain change where evidence, traceable decisions and cross-functional implementation matter.
At risk: technical suitability · award quality · implementation pace · supply resilience
Describe the situation Typical pressure points
When the operating system stops aligning.
- A new technology requires a robust technical and commercial partner decision.
- Risk, opportunity, quality and cost criteria are evaluated in separate workstreams.
- Growth exposes gaps between procurement, suppliers, operations and ERP data.
- A transformation needs stronger ownership without overstating specialist regulatory scope.
Where the mandate can start
Connect business risk to executable ownership.
01Structured sourcing
Build a transparent tender and evaluation process around technical fit, quality, figures, risks and opportunities.
Structured sourcing 02Project decision system
Clarify facts, dependencies, owners and escalation logic before commitments become costly to reverse.
Project decision system 03Implementation ownership
Coordinate cross-functional execution and management decisions through a defined transformation phase.
Implementation ownership Initial control questions
Establish the decision base before adding activity.
- 01Which technical and commercial assumptions still lack a shared evidence base?
- 02Which supplier or technology risk could become expensive after award?
- 03Which interface needs one accountable decision owner now?